Correlation Between Ventyx Biosciences and Keros Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Keros Therapeutics, you can compare the effects of market volatilities on Ventyx Biosciences and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Keros Therapeutics.

Diversification Opportunities for Ventyx Biosciences and Keros Therapeutics

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Ventyx and Keros is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Keros Therapeutics go up and down completely randomly.

Pair Corralation between Ventyx Biosciences and Keros Therapeutics

Given the investment horizon of 90 days Ventyx Biosciences is expected to generate 2.05 times more return on investment than Keros Therapeutics. However, Ventyx Biosciences is 2.05 times more volatile than Keros Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Keros Therapeutics is currently generating about -0.01 per unit of risk. If you would invest  221.00  in Ventyx Biosciences on August 31, 2024 and sell it today you would earn a total of  44.00  from holding Ventyx Biosciences or generate 19.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ventyx Biosciences  vs.  Keros Therapeutics

 Performance 
       Timeline  
Ventyx Biosciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ventyx Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Ventyx Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Keros Therapeutics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Keros Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Keros Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Ventyx Biosciences and Keros Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ventyx Biosciences and Keros Therapeutics

The main advantage of trading using opposite Ventyx Biosciences and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.
The idea behind Ventyx Biosciences and Keros Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments